By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Civitas Therapeutics 

190 Everett Ave.

Chelsea  Massachusetts  02150  U.S.A.
Phone: 617-968-3004 Fax: n/a



Company News
Cowen: Acorda Therapeutics (ACOR) Not Worried About Civitas Therapeutics' New Parkinson's Drug 11/20/2014 1:08:32 PM
Acorda Therapeutics (ACOR) Completes Acquisition Of Civitas Therapeutics 10/23/2014 11:15:49 AM
Acorda Therapeutics (ACOR) Snaps Up Civitas Therapeutics In $525M Cash Deal 9/24/2014 5:55:54 AM
A Day After Nabbing $55 Million, Parkinson's Biotech Civitas Therapeutics Files For $86 Million IPO 8/27/2014 6:13:03 AM
Massachusetts' Civitas Therapeutics Locks In $55 Million 8/25/2014 4:15:17 PM
Civitas Therapeutics Announces Positive Phase 2b Results For CVT-301, Inhaled Levodopa For The Treatment Of Parkinson’s Disease 4/28/2014 9:29:09 AM
Civitas Therapeutics To Present At The 21st Annual Future Leaders In The Biotech Industry Conference 3/24/2014 9:30:47 AM
Civitas Therapeutics To Present At Cowen and Company 34th Annual Health Care Conference 2/25/2014 7:31:27 AM
Civitas Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/6/2014 7:24:42 AM
Civitas Therapeutics Appoints Mark Iwicki President And Chief Executive Officer 1/29/2014 7:21:59 AM